The House Energy and Commerce (E&C) Committee, which has jurisdiction over the 340B and Medicaid programs, held its first meeting [...] …
Articles by : Bella Czajkowski, National Correspondent
Drugmakers Bristol Myers Squibb (BMS) and Vertex have each announced changes to their 340B contract pharmacy restrictions that apply to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Participation in the 340B program did not increase the number of vulnerable patients beginning targeted care for prostate cancer, a [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Four drugmakers have notified 340B covered entities of changes to certain national drug codes (NDC) for their products over the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major hospital advocacy group recently warned that October 2024 agency guidance on Medicare drug price negotiations may allow drugmakers [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
An influential Indiana state legislator plans to soon reintroduce legislation that would add extensive 340B reporting requirements for all 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
AbbVie’s latest move to extend certain 340B contract pharmacy restrictions to federal grantees also appears to target hospitals’ use of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A San Diego-based drugmaker recently notified 340B covered entities of manufacturing and drug code changes for an antibiotic used to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B Report [...] …